3

FORM 3

Company: REVIVA PHARMACEUTICALS HOLDINGS, INC.
Filed: August 20, 2018
Period of Report: August 20, 2018
Accession Number: 0001144204-18-045670

View Document ↗ View on SEC.gov ↗